Medivolve Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
David Preiner
Chief executive officer
CA$4.1m
Total compensation
CEO salary percentage | 6.4% |
CEO tenure | 3.1yrs |
CEO ownership | 24.6% |
Management average tenure | no data |
Board average tenure | 4.1yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Dec 31 2023 | n/a | n/a | -CA$4m |
Sep 30 2023 | n/a | n/a | -CA$9m |
Jun 30 2023 | n/a | n/a | -CA$10m |
Mar 31 2023 | n/a | n/a | -CA$20m |
Dec 31 2022 | CA$4m | CA$260k | -CA$15m |
Sep 30 2022 | n/a | n/a | -CA$7m |
Jun 30 2022 | n/a | n/a | CA$2m |
Mar 31 2022 | n/a | n/a | CA$2m |
Dec 31 2021 | CA$1m | CA$146k | -CA$7m |
Compensation vs Market: David's total compensation ($USD2.97M) is above average for companies of similar size in the US market ($USD674.46K).
Compensation vs Earnings: David's compensation has increased whilst the company is unprofitable.
CEO
David Preiner
3.1yrs
Tenure
CA$4,059,393
Compensation
Mr. David Preiner is Founder, President, CEO and Director of Exponential Genomics Inc. He studied at Harvard University (Ext. BLA candidate) - Biology, Engineering Sciences, Nanotechnology and has experien...
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Member of Advisory Board | 4.1yrs | no data | no data | |
Member of Strategic Advisory Board | 4.1yrs | no data | no data | |
Member of Advisory Board | 4yrs | no data | no data | |
Member of Advisory Board | no data | no data | no data | |
Member of Strategic Advisory Board | 4.1yrs | no data | no data | |
Member of Advisory Board | 4.1yrs | no data | no data | |
Member of Advisory Board | 4.1yrs | no data | no data |
4.1yrs
Average Tenure
Experienced Board: MEDV.F's board of directors are considered experienced (4.1 years average tenure).